Erymax 250mg Pill - orange clear capsule/oblong, 22mm
Pill with imprint Erymax 250mg is Orange / Clear, Capsule/Oblong and has been identified as Erythromycin Delayed-Release 250 mg. It is supplied by Midlothian Laboratories.
Erythromycin is used in the treatment of Bronchitis; Bacterial Endocarditis Prevention; Bowel Preparation; Bartonellosis; Otitis Media and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Erythromycin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Erymax 250mg
Erythromycin Delayed-Release
- Imprint
- Erymax 250mg
- Strength
- 250 mg
- Color
- Orange / Clear
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Macrolides
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Midlothian Laboratories
- National Drug Code (NDC)
- 68308-0250
- Inactive Ingredients
-
FD&C Yellow No. 6,
titanium dioxide
Note: Inactive ingredients may vary.
More about erythromycin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (65)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: macrolides
- Breastfeeding
- En español
Patient resources
- Erythromycin drug information
- Erythromycin (Intravenous) (Advanced Reading)
- Erythromycin (Oral) (Advanced Reading)
- Erythromycin Delayed-Release Tablets and Capsules
- Erythromycin Tablets
Other brands
Erythrocin, E.E.S. Granules, Ilosone, EryPed, ... +4 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.